Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria

Clinical trial NCT06819774 · RECRUITING

Trial details

NCT number: NCT06819774
Sponsor: Shandong New Time Pharmaceutical Co., LTD
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Urticaria

Start date: 2024-04-22
Primary completion: 2025-08-01
Enrollment: 284

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.